ATXN10

Ataxin-10 · Q9UBB4 · ATXN10 on Sugi Atlas →

0 patent compounds predicted against ATXN10, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ATXN10 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL) PHASE3COMPLETED
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD PHASE1/PHASE2RECRUITING
Efficacy Study of Epoetin Alfa in Friedreich Ataxia PHASE2COMPLETED
Study of CAD-1883 for Spinocerebellar Ataxia PHASE2WITHDRAWN
Safety and Efficacy of Etravirine in Friedreich Ataxia Patients PHASE2COMPLETED
An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 in Patients with Chronic Stroke PHASE2COMPLETED
A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia PHASE2COMPLETED
Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 PHASE1RECRUITING
Clinical Trial Readiness for SCA1 and SCA3 nanUNKNOWN
Genetic Mechanism of Conserved Ancestral Haplotype in SCA10 nanUNKNOWN
Natural History of Spinocerebellar Ataxia Type 7 (SCA7) nanRECRUITING
Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD - BIGPRO Study Astrocytes nanUNKNOWN
Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD nanUNKNOWN
Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) nanCOMPLETED
Biomarkers in Autosomal Dominant Cerebellar Ataxia nanCOMPLETED
Integrated Functional Evaluation of the Cerebellum nanCOMPLETED
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias nanUNKNOWN
Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial nanUNKNOWN
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases nanACTIVE_NOT_RECRUITING
Efficacy of Stabilometric Platform to Improve Standing Balance in Patients With Friedreich's Ataxia nanRECRUITING
Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias nanCOMPLETED
Hong Kong Spinocerebellar Ataxias Registry nanRECRUITING
Characteristics of Episodic Ataxia Syndrome nanCOMPLETED
Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias nanRECRUITING
Core Stability Exercises and Hereditary Ataxia nanCOMPLETED
Neuropsychiatry and Cognition in SCA3/MJD nanUNKNOWN
Sporadic Degenerative Ataxia With Adult Onset: Natural History Study nanRECRUITING
FA Clinical Outcome Measures nanACTIVE_NOT_RECRUITING
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias nanCOMPLETED
Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ATXN10 binder may also engage these)

ProteinNameSimilarity
Q4R4Y2 1.000 Q4R4Y2 →
Q5RE06 1.000 Q5RE06 →
Q2TBW0 1.000 Q2TBW0 →
Q9ER24 0.999 Q9ER24 →
P28658 0.998 P28658 →
Q5FVB0 0.988 Q5FVB0 →
Q0V9L1 0.984 Q0V9L1 →
Q0P5A6 0.984 Q0P5A6 →
Q9D2C2 0.984 Q9D2C2 →
Q95LY5 0.982 Q95LY5 →
Q9YHB5 0.982 Q9YHB5 →
Q80ZJ6 0.981 Q80ZJ6 →
Q6WRX3 0.981 Q6WRX3 →
Q803M5 0.981 Q803M5 →
Q5IFJ8 0.981 Q5IFJ8 →
SAAL1 Protein SAAL1 0.981 landscape →
Q9H892 0.980 Q9H892 →
Q9BPX3 0.980 Q9BPX3 →
Q3URY6 0.980 Q3URY6 →
B1WBW4 0.980 B1WBW4 →
Q5RAG3 0.980 Q5RAG3 →
A2VE70 0.980 A2VE70 →
P0C6R2 0.979 P0C6R2 →
PSMD5 26S proteasome non-ATPase regulatory subunit 5 0.979 landscape →
Q6NVK9 0.979 Q6NVK9 →
TTI1 TELO2-interacting protein 1 homolog 0.979 landscape →
Q66L58 0.979 Q66L58 →
Q6DCF2 0.979 Q6DCF2 →
Q9D0L7 0.979 Q9D0L7 →
Q6PIY5 0.979 Q6PIY5 →